MedGenome acquires Prognosis Labs
• Strategic acquisition to accelerate MedGenome’s growth and geographic penetration
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
MedGenome Labs
MedGenome launches FSHD1 genetic screening test
The FSHD1 Optical Genome Mapping Test (OGM) is advanced diagnostic tool that uses technology to provide a comprehensive and…
MedGenome Labs launches clonoSEQ in India
The clonoSEQ test can detect and monitor MRD in patients with certain types of blood cancer
MedGenome labs to expand diagnostic portfolio through trident diagnostics acquisition
This acquisition will help expand the access to tests to consumers in tier II and III markets
Experts develop genetic risk score to predict heart disease in South Asia
Findings and methods developed can be used to screen large populations and high-risk individuals at a cost less than Rs 5000,…
- Advertisement -
MedGenome Labs collaborates with Dr Iravathams Clinical Laboratory Hyderabad
The partnership with Dr Iravathams lab will help integrate MedGenome’s flagship innovation SPIT-SEQ, with various tests offered by…
College of American Pathologist awards accreditation to MedGenome Labs
The accreditation programme is recognised as maintaining high standards for laboratory quality and having most up-to-date…
College of American Pathologist awards accreditation to MedGenome Labs
The accreditation programme is recognised as maintaining high standards for laboratory quality and having most up-to-date…
Betting big on big data
The concept of big data, which has risen manifolds in recent years, is going to be a turning point for the diagnostics sector
Our one test can find more resistant superbugs than all our competitors
More than three decade old molecular biology company XCyton Diagnostics has already carved its presence in the Indian market and…